See every side of every news story
Published loading...Updated

Biotronik’s Freesolve resorbable scaffold to be studied in long lesions - Cardiovascular News

Summary by Cardiovascular News
Biotronik has announced the launch of BIOMAG-LL, a pre-market trial focused on confirming the safety and clinical performance of Freesolve resorbable magnesium scaffold (RMS), for the treatment of long de novo lesions in native coronary arteries. BIOMAG-LL is a prospective, international, multicentre, single arm premarket study that will enrol 100 patients in Europe with de novo coronary artery stenosis and long lesions. Given that the Freesolve…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cardiovascular News broke the news in on Wednesday, February 19, 2025.
Sources are mostly out of (0)